Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OpGen Announces Formation of Public Health Consortium

Published: Friday, May 18, 2012
Last Updated: Friday, May 18, 2012
Bookmark and Share
Consortium to evaluate whole genome mapping for improved genetic analysis of disease outbreaks.

OpGen, Inc. announced the formation of a public health consortium to evaluate OpGen's Whole Genome Mapping technology as an enhanced method for strain typing microorganisms that cause disease outbreaks. The consortium is comprised of the Association of Public Health Laboratories (APHL), the Centers for Disease Control and Prevention (CDC), the University of Maryland Institute for Genome Sciences, and 11 state public health laboratories from across the United States.

The rise in disease outbreaks due to food borne illnesses and hospital acquired infections poses an ongoing threat to public health. Public health officials and healthcare organizations need access to improved first responder technologies to rapidly identify disease causing agents in order to effectively control and contain outbreaks and treat patients. Today's genotyping technologies, such as PFGE, are limited in the type of information they provide for microbial strain typing. OpGen's Whole Genome Mapping technology provides a rapid, comprehensive structural analysis of microbial genomes that, combined with sequencing, provides a new genetic analysis workflow that more accurately detects important genetic elements associated with virulence and drug resistance. The Whole Genome Map data can be used to guide sequencing of these targeted regions to enable more accurate understanding and response management at an early stage in outbreaks. The initial results from the consortium study will be presented on May 20th at the APHL annual meeting in Seattle, WA.

"We are extremely pleased to be working with our consortium partners to evaluate Whole Genome Mapping as an enhanced genetic analysis technology for confirmation and management of disease outbreaks," said Douglas White, chief executive officer of OpGen. "The level of accuracy and discrimination that is achieved by combining Whole Genome Mapping and next generation sequencing can enable a new paradigm for outbreak management."

The purpose of the consortium is to demonstrate the capabilities of Whole Genome Mapping as a more effective genomics analysis technology for outbreak analysis. "Public Health Laboratories operate as a first line of defense to protect the public against diseases and other health hazards, and as such we need to be using cutting-edge technologies to identify, address and protect the public from health risks," said Scott Becker, APHL executive director. "We are pleased to be part of this new consortium that brings together leaders in the public health field to collaborate on the use of new genomic analysis technologies to better identify and manage disease outbreaks."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OpGen Assists 100K Genome Project
OpGen, Inc. has entered into a scientific and technical partnership with UC Davis in cooperation with the 100K Genome Project to create high resolution microbial genetic maps.
Thursday, December 20, 2012
OpGen Announces Strategic Collaboration with IQT
The collaboration is focused on developing a new high-throughput sequence and genome mapping pipeline for microbial genome analysis.
Tuesday, May 01, 2012
OpGen's Whole Genome Mapping System Features at International Plant & Animal Genome XX Conference
The company announced today that the company's new Whole Genome Mapping and Genome Builder(TM) software was featured in a poster session at the International Plant & Animal Genome XX Conference, January 14-18, 2012 in San Diego.
Tuesday, January 17, 2012
OpGen Strengthens Management Team to Accelerate Commercialization Strategy
Whole genome analysis company appoints new CIO and names key executive positions.
Thursday, December 22, 2011
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Antibiotics Discovered While Sifting Through Human Microbiome
Researchers identify genes in a microbe’s genome that produce antibiotic compounds, then synthesize them without the need for bacterial culture.
A Genome-wide View of Human DNA Viruses
In this study, Duplex sequencing was used to accurately analyse the genome-wide rate of spontaneous mutation of human adenovirus C5 (HAdv5).
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Rare Immunodeficiency Yields Unexpected Insights
Scientists uncover previously unknown gene mutation revealing the role of a key molecule involved in immune cell development.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!